Boston Financial Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $66.7M | Buy |
287,243
+4,880
| +2% | +$1.12M | 2.01% | 10 |
|
|
2024
Q3 | $62.3M | Sell |
282,363
-10,809
| -4% | -$2.24M | 1.86% | 12 |
|
|
2024
Q2 | $57.6M | Sell |
293,172
-348
| -0.1% | -$71.9K | 1.83% | 11 |
|
|
2024
Q1 | $63.2M | Buy |
293,520
+136,044
| +86% | +$28.6M | 2.01% | 10 |
|
|
2023
Q4 | $33.2M | Sell |
157,476
-2,609
| -2% | -$557K | 1.12% | 29 |
|
|
2023
Q3 | $32.1M | Sell |
160,085
-1,991
| -1% | -$396K | 1.2% | 26 |
|
|
2023
Q2 | $30M | Buy |
162,076
+477
| +0.3% | +$88.2K | 1.09% | 29 |
|
|
2023
Q1 | $30.9M | Buy |
161,599
+6,675
| +4% | +$1.21M | 1.21% | 26 |
|
|
2022
Q4 | $26.1M | Sell |
154,924
-3,517
| -2% | -$611K | 1.05% | 29 |
|
|
2022
Q3 | $28.1M | Buy |
158,441
+2,145
| +1% | +$424K | 1.22% | 26 |
|
|
2022
Q2 | $32M | Sell |
156,296
-531
| -0.3% | -$113K | 1.38% | 24 |
|
|
2022
Q1 | $37.3M | Sell |
156,827
-5,109
| -3% | -$1.2M | 1.42% | 22 |
|
|
2021
Q4 | $37M | Sell |
161,936
-2,659
| -2% | -$585K | 1.35% | 26 |
|
|
2021
Q3 | $31.8M | Sell |
164,595
-1,030
| -0.6% | -$209K | 1.3% | 28 |
|
|
2021
Q2 | $35.2M | Buy |
165,625
+3,706
| +2% | +$782K | 1.42% | 25 |
|
|
2021
Q1 | $33.1M | Buy |
161,919
+5,276
| +3% | +$1.04M | 1.45% | 24 |
|
|
2020
Q4 | $28.5M | Sell |
156,643
-4,135
| -3% | -$703K | 1.3% | 28 |
|
|
2020
Q3 | $26.9M | Sell |
160,778
-1,373
| -0.8% | -$231K | 1.31% | 27 |
|
|
2020
Q2 | $26.4M | Buy |
162,151
+7,979
| +5% | +$1.43M | 1.42% | 24 |
|
|
2020
Q1 | $26.7M | Buy |
154,172
+7,121
| +5% | +$1.42M | 1.71% | 20 |
|
|
2019
Q4 | $29.5M | Buy |
147,051
+632
| +0.4% | +$130K | 1.62% | 19 |
|
|
2019
Q3 | $30.9M | Buy |
146,419
+228
| +0.2% | +$47.6K | 1.76% | 15 |
|
|
2019
Q2 | $28.4M | Buy |
146,191
+37,264
| +34% | +$6.87M | 1.64% | 20 |
|
|
2019
Q1 | $17.9M | Buy |
108,927
+4,235
| +4% | +$749K | 1.09% | 29 |
|
|
2018
Q4 | $19.7M | Buy |
104,692
+3,237
| +3% | +$598K | 1.36% | 19 |
|
|
2018
Q3 | $17.3M | Buy |
101,455
+6,817
| +7% | +$1.15M | 1.02% | 33 |
|
|
2018
Q2 | $15.5M | Buy |
94,638
+230
| +0.2% | +$37.6K | 1.05% | 33 |
|
|
2018
Q1 | $15.3M | Sell |
94,408
-2,043
| -2% | -$325K | 1.04% | 29 |
|
|
2017
Q4 | $14.1M | Buy |
96,451
+207
| +0.2% | +$29.5K | 0.94% | 37 |
|
|
2017
Q3 | $13.1M | Buy |
96,244
+2,250
| +2% | +$284K | 0.93% | 38 |
|
|
2017
Q2 | $11.8M | Buy |
93,994
+2,557
| +3% | +$306K | 0.85% | 36 |
|
|
2017
Q1 | $10.9M | Buy |
91,437
+3,921
| +4% | +$472K | 0.81% | 39 |
|
|
2016
Q4 | $10.1M | Buy |
87,516
+2,032
| +2% | +$226K | 0.8% | 36 |
|
|
2016
Q3 | $8.94M | Buy |
85,484
+40,738
| +91% | +$4.25M | 0.73% | 37 |
|
|
2016
Q2 | $4.36M | Buy |
+44,746
| New | +$4.23M | 0.36% | 105 |
|
Other funds holding CME
Boston Financial Management's CME Position: Q4 2024 in Review
Boston Financial Management increased its CME Group (CME) stake by 1.7% in Q4 2024, buying an estimated $1.12M and bringing the position to 287,243 shares worth $66.7M. The position accounts for 2.01% of the portfolio, ranked #10.
Boston Financial Management first reported a position in CME in Q2 2016 and has held it in 35 quarters since. 1,500 funds tracked by Wall St. Rank hold CME as of Q4 2024.
- Boston Financial Management held 287,243 shares of CME Group worth $66.7M as of Q4 2024.
- Boston Financial Management bought 4,880 CME Group shares in Q4 2024, an estimated $1.12M.
- CME Group made up 2.01% of Boston Financial Management's portfolio in Q4 2024, its #10 holding.
- Boston Financial Management first reported a position in CME Group in Q2 2016 and has held it in 35 quarters since.
- 1,500 funds tracked by Wall St. Rank held CME Group as of Q4 2024.
Based on Boston Financial Management's 13F filing for Q4 2024, filed 3 Feb 2025.